Primary Growth Hormone (GH) Insensitivity and Insulin-Like Growth Factor Deficiency Caused by Novel Compound Heterozygous Mutations of the GH Receptor Gene: Genetic and Functional Studies of Simple and Compound Heterozygous States
Open Access
- 1 June 2007
- journal article
- case report
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 92 (6) , 2223-2231
Abstract
Context: Primary GH insensitivity (GHI) or Laron syndrome, caused by mutations of the GH receptor (GHR) gene, has a clinical phenotype of postnatal growth failure associated with normal elevated serum concentrations of GH and low serum levels of IGF-I. Objective: We investigated the clinical and biochemical implications of molecular defects in the GHR gene in an Austrian family with two daughters who were GHI. Patients: Patient 1 [height, −4.8 sd score (SDS)] and patient 2 (height, −5.0 SDS) had elevated circulating levels of GH, low-normal levels of GH-binding protein, and abnormally low IGF-I (−5.0 SDS and −2.6 SDS, respectively) and IGF-binding protein-3 (−2.6 SDS and −2.0 SDS, respectively). Results: Both patients carry novel compound, missense, heterozygous GHR mutations, C94S and H150Q. In vitro reconstitution experiments demonstrated that whereas each of the mutants could be stably expressed, GHR(C94S) lost its affinity for GH and could neither activate signal transducer and activator of transcription (STAT)-5b nor drive STAT5b-dependent gene transcription in response to GH (1–100 ng/ml). GHR(H150Q) showed normal affinity for GH but impaired capacity for signal transduction. The compound heterozygote and C94S heterozygote, but not the H150Q heterozygote, showed significant deficiency in activating GH-induced gene expression, corroborating diminished GH-induced STAT5b activation in fibroblasts carrying GHR(C94S) as either a compound heterozygote (in the patients) or a simple heterozygote (in one parent). Conclusions: Each of the compound heterozygous mutations contributed additively to the pathological condition seen in the patients, and the more detrimental of the two mutations, C94S, may cause (partial) primary GHI, even in a heterozygous state.Keywords
This publication has 28 references indexed in Scilit:
- Disulfide bonds determine growth hormone receptor folding, dimerisation and ligand bindingJournal of Cell Science, 2006
- Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disordersNature Clinical Practice Endocrinology & Metabolism, 2006
- Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathwayExperimental Cell Research, 2006
- Model for growth hormone receptor activation based on subunit rotation within a receptor dimerNature Structural & Molecular Biology, 2005
- A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormoneNature Genetics, 2004
- Transcriptional Regulation of Insulin-like Growth Factor-I by Interferon-γ Requires STAT-5bJournal of Biological Chemistry, 2004
- Growth Hormone (GH)-induced Dimerization Inhibits Phorbol Ester-stimulated GH Receptor ProteolysisJournal of Biological Chemistry, 2001
- Species-specific Alternative Splice Mimicry at the Growth Hormone Receptor Locus Revealed by the Lineage of Retroelements during Primate EvolutionJournal of Biological Chemistry, 2000
- A dominant-negative mutation of the growth hormone receptor causes familial short statureNature Genetics, 1997
- The Role of Receptor Dimerization Domain Residues in Growth Hormone SignalingJournal of Biological Chemistry, 1997